1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Painful Diabetic Neuropathies: new trials by email Literature Review of Painful Diabetic Neuropathies trials Research Report on Painful Diabetic Neuropathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy Low Dose: 16 mg Engensis (VM202), High Dose: 32 mg Engensis (VM202), Control- Placebo (normal saline) - Painful Diabetic Neuropathies | Phase 2 | Completed | Helixmith Co., Ltd. | 104 | 2012-08-01 | 2025-10-06 |
Diabetic Neuropathies (1) · Hypesthesia (1) · Neuralgia (1) · Paresthesia (1)
Diabetes Complications (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Diseases (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Peripheral Nervous System Diseases (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Somatosensory Disorders (1)
Genetic Therapy (1) · Saline Solution (1)
South Korea (1) · United States (1)
Jack Kessler, MD (1)